With over 22 years of experience in clinical research and pharmaceutical services, Barry Simms has dedicated his career to advancing the development of novel therapeutics through expert organizational leadership. His executive management skills are showcased in his oversight of large-scale operations including project management, clinical kitting, accessioning, and biorepository for companies with more than 700 employees, while his notable proficiency in business development is exemplified in his experience with high-growth, private equity-owned organizations, oversight of global laboratory partnership programs, and work enhancing operational efficiency, productivity, and consistency with private equity owners and Boards of Directors. Prior to Elligo, Simms was Chief Operating Officer and Interim CEO at LabConnect, and a Senior Executive for several research organizations. He earned a B.S. in accounting from the University of Virginia at Wise and an MBA from King University. He has also received several accolades including an Outstanding Achievement in Accounting Award and placement on the Executive Steering Committee of PharmaTimes.